Background: Reports have implicated Aspartame (N-L-a-aspartyl-L-phenylalanine methyl ester, ASP) in neurological problems. Aim: To evaluate Na þ , K þ -ATPase activities in human erythrocyte membranes after incubation with the ASP metabolites, phenylalanine (Phe), methanol (MeOH) and aspartic acid (Asp). Methods: Erythrocyte membranes were obtained from 12 healthy individuals and were incubated at 371C for 1 h with the sum or each of the ASP metabolites separately, which are commonly measured in blood after ASP ingestion. Na þ , K þ -ATPase and Mg 2 þ -ATPase activities were measured spectrophotometrically. Results: Membrane Mg 2 þ -ATPase activity was not altered. The sum of ASP metabolite concentrations corresponding to 34, 150 or 200 mg/kg of the sweetener ingestion resulted in an inhibition of the membrane Na þ , K þ -ATPase by À30, À40, À48%, respectively. MeOH concentrations of 0.14, 0.60 or 0.80 mM decreased the enzyme activity by À25, À38, À43%, respectively. Asp concentrations of 2.80, 7.60 or 10.0 mM inhibited membrane Na þ , K þ -ATPase by À26, À40, À46%, respectively. Phe concentrations of 0.14, 0.35 or 0.50 mM reduced the enzyme activity by À24, À44, À48%, respectively. Preincubation with L-cysteine or reduced glutathione (GSH) completely or partially restored the inhibited membrane Na þ , K þ -ATPase activity by high or toxic ASP metabolite concentrations. Conclusions: Low concentrations of ASP metabolites had no effect on Na þ , K þ -ATPase activity. High or abuse concentrations of ASP hydrolysis products significantly decreased the membrane enzyme activity, which was completely or partially prevented by L-cysteine or reduced GSH.
Introduction
Aspartame (N-L-a-aspartyl-L-phenylalanine methyl ester, ASP) is an artificial sweetener introduced in the USA in 1981 for selected foods, and in 1983 for carbonated drinks. Following amide and ester hydrolysis, ASP is metabolized to aspartic acid (Asp), methanol (MeOH) and phenylalanine (Phe), with serum levels of all three metabolites increasing after ingestion of modest amounts (Pardridge, 1986; Janssen and van der Heijden, 1988) .
Clinical studies have demonstrated that administration of ASP can alter some aspects of blood chemistry, in particular, plasma Phe levels (Janssen and van der Heijden, 1988 ) and brain wave activity among epileptic children (Camfield et al., 1992) Moreover, since ASP approval, numerous case reports have implicated ASP in the occurrence of such problems as seizures (Camfield et al., 1992) , headache (Van den Eeden et al., 1994; Strong, 2000) , panic attacks and oncogenesis (Roberts, 1988; Karikas et al., 1998) .
The majority of clinical studies investigating ASP have used as subjects healthy adults, those with a typical Phe metabolism disorder such as phenylketonurics (PKU) and individuals likely to use large amounts of ASP (Roberts, 1988) .
In our previous in vivo study (Schulpis et al., 2002) , (Na þ , K þ )-ATPase and Mg 2 þ -ATPase activities in the erythrocyte membranes from PKU patients 'off diet', in whom Phe blood concentrations were remarkably elevated, were found reduced. On the contrary, in our previous in vitro study (Doulgeraki et al., 2002) , Mg 2 þ -ATPase activity was not affected when incubated, with high concentrations of the aromatic acid. Additionally, L-cysteine (cys) and reduced glutathione (GSH) reversed the inhibition of rat brain Na þ , K þ -ATPase activity induced by free radicals (Tsakiris et al., 2000) . As ASPs' use has been widespread, it was important to evaluate the enzyme Na þ , K þ -ATPase and Mg 2 þ -ATPase activities in the human erythrocyte membranes after incubation with various concentrations of ASP metabolites and to investigate the possible mechanism of their action.
Subjects and methods

Subjects
The study population consisted of 12 healthy individuals, mean age of 2475 years. The study was approved by the Greek Ethics Committee, conducted according to the principles expressed in the declaration of Helsinki.
Erythrocyte membrane preparation
Venous blood samples (7.0 ml) were collected into heparinized blood collection tubes from the individuals. Within 2 h of collection, the erythrocytes were sedimented by centrifugation at 2000 g for 30 min at 41C, washed three times, after three similar centrifugations, with a buffer solution (250 mM, tris (hydroxymethyl) aminomethaneHCl (Tris-HCl), pH 7.4, 140 mM NaCl, 1 mM MgCl 2 10 mM glucose). The erythrocytes were then resuspended in 1.0 ml of this buffer and stored at 41C for up to 24 h before erythrocyte membrane preparation. The washed erythrocytes were lysed after freeze (À801C)-thawing (501C) for five times, as described by Galbraith and Watts (1980) and Kamber et al. (1984) . The hemolysate was centrifuged at 35 000 g for 30 min with 40-60 vol of cold 0.1 mol/l Tris-HCl, pH 7.4, four times until a whitish pink color appeared. Membranes were suspended in 0.1 mol/l Tris-HCl, pH 7.4, to a final concentration of 2 mg protein/ml. The protein content was determined, as described previously (Lowry et al., 1951) . Membranes stored at À401C retained the enzyme activities for at least 2 weeks. The minor hemoglobin that remained attached to the membrane surface was measured with the kit 527-A (Sigma Chemicals Co., St Louis, MO, USA), and the value was substracted from the total protein concentration.
Evaluation of erythrocyte membrane Na þ , K þ -ATPase and Mg 2 þ -ATPase activities after incubation with ASP metabolites (Bowler and Tirri, 1974) Erythrocyte membrane Na þ , K þ -ATPase and Mg 2 þ -ATPase activities were evaluated after incubation with ASP metabolites at 371C as shown in Tables 1 and 2 . ASP follows a hydrolysis process in the laboratory giving MeOH, Asp and Phe 10:40:50 (w/w/w) (Janssen and van der Heijden, 1988) . Furthermore, the concentrations of ASP hydrolysis products measured in the human plasma, after its ingestion, were different and previously reported by Stegink (1987) . So, we adapted to use the concentrations of ASP degradation parts (Phe, Asp, MeOH), which are commonly determined in the blood of ASP consumers as follows: ASP ingestion of 10 mg/ kg (Mix 1: Asp 0.8 mM þ Phe 0.07 mM, MeOH ¼ not detected) represents the additive and its components when drinking a beverage (12 oz). ASP intake of 34 mg/kg (Mix 2: MeOH 0.14 mM þ Asp 2.80 mM þ Phe 0.14 mM) represents the 99th percentile of projected daily ingestion, whereas ASP 150 mg/kg (Mix 3: MeOH 0.60 mM þ Asp 7.60 mM þ Phe 0.35 mM) or 200 mg/kg (Mix 4: MeOH 0.80 mM þ Asp 10.0 mM þ Phe 0.50 mM) may be taken by accident (Stegink, 1987) . Na þ , K þ -ATPase activity was calculated as the difference between total ATPase activity (Na
and Mg 2 þ -dependent ATPase activity. Total ATPase activity was assayed at 371C in an incubation medium consisting of 50 mM MgCl 2 , 1 mM ethylenodiaminotetraacetic acid K 2 -salt (K þ -EDTA), 3 mM disodium ATP and 80-100 mg protein of the membranes in a final volume of 1 ml. Ouabain (1 mM) 
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was added to determine the activity of the Mg 2 þ -ATPase.
The values of Mg 2 þ -dependent ATPase were similar in the presence of ouabain in the reaction mixture, as also in the absence of ouabain and without NaCl and KCl (in the presence of MgCl 2 only). The reaction was started by adding ATP and stopped after a 30 min incubation period by the addition of 2 ml of a mixture of 1% ammonium molybdate in 0.9 mol/l H 2 SO 4 . The yellow color that developed was read at 390 nm. The experimental procedures were performed in each subject erythrocyte membranes (n ¼ 12) and the measurement study was performed three times for each sample.
Preincubation of various concentrations of ASP metabolites with erythrocyte membranes in the presence of L-cysteine (cys) or reduced GSH Mix 2 or Mix 4 (see Table 3 ) was preincubated with 100 mg protein of erythrocyte membranes from each subject (n ¼ 12), in the presence or absence of cys (0.83 mM) or GSH (0.83 mM) for 1 h at 371C. Then, the erythrocyte membrane Na þ , K þ -ATPase activities were evaluated in the reaction mixture. Cys concentration of 0.83 mM is usually found in the plasma of humans, who are supplemented with cys (500 mg/day, orally) as an antioxidant compound (Murakami and Webb, 1981) .
Statistics
Data were analyzed by one-way ANOVA. P-values o0.05 were considered statistically significant.
Results
As illustrated in Table 1 , the amount of ASP metabolites, which correlates with the consumption of a beverage, did not alter Na þ , K þ -ATPase activity when incubated with erythrocyte membranes. On the contrary, the sum of ASP hydrolysis product concentrations, which corresponded to the 99th percentile of the daily intake of the sweetener as well as toxic doses (150 or 200 mg/kg) taken by accident, resulted in a remarkable decrease of the human erythrocyte membrane enzyme activity. With regard to the metabolite MeOH (see Table 2 ), statistically significant inhibition of Na þ , K þ -ATPase activity was observed after incubation of the erythrocyte membranes with concentrations commonly determined in blood and related to ASP (34 mg/kg/24 h) consumption or with those measured in blood after ingestion of abuse doses (150 or 200 mg ASP/kg/24 h), In addition, incubation of the erythrocyte membranes with concentrations of the dicarboxylic acid Asp, evaluated in blood and correlated with ASP ingestion 34, 150 or 200 mg/kg, resulted in a reduction of Na þ , K þ -ATPase activity. Furthermore, concentrations of the aromatic acid corresponding to the blood levels, usually found after high or toxic doses of ASP ingestion, remarkably inhibited the enzyme activity after 1 h incubation. Lower Aspartame vs Na þ , K þ -ATPase KH Schulpis et al concentrations of Phe had no effect on the membrane Na þ , K þ -ATPase activity (Table 2) .
Human erythrocyte membrane Mg 2 þ -ATPase activity was not altered. The enzyme activities after incubation of membranes with various concentrations of ASP metabolites did not differ as compared to the control value 3.2070.22 mmol Pi/h Â mg protein (P40.05).
As shown in Table 3 , cys or GSH alone did not alter the membrane Na þ , K þ -ATPase activity. In contrast, the addition of the antioxidants completely or partially prevented the inhibition of the membrane enzyme by Mix 2 or Mix 4, respectively.
Discussion
The science of toxicology is based on the premise that all compounds are toxic at some doses. Salt, water, sugar and even a mother's love produce deleterious effects, when not given in appropriate amounts. Thus, it is not surprising that very large doses of ASP or its component parts (Asp, Phe and MeOH) produce deleterious effects in sensitive animal species. The critical question is whether ASP is potentially harmful at normal and at abuse levels of use (Stegink, 1987; Janssen and van der Heijden, 1988) . Orally ingested ASP is absorbed and metabolized as mentioned above. The components are absorbed from the intestinal lumen and reach the portal blood in a manner similar to that of amino acids and MeOH arising from dietary protein or polysaccharides (Stegink, 1987) . In either case, the ingestion of large doses of ASP releases Asp, Phe and MeOH in the portal blood (Stegink, 1987; Roberts, 1988) , and these compounds must be metabolized and/or excreted.
Objections to the use of ASP as a food additive have been based on concerns about the potential toxicity of each of its three components (Stegink, 1987) .
In this study, low concentrations of the component Phe had no effect on Na þ , K þ -ATPase activity. On the contrary, high or toxic Phe concentrations resulted in a significant reduction of the membrane enzyme activity. As shown in our previous study (Doulgeraki et al., 2002) , a direct inactivating effect on Na þ , K þ -ATPase by high Phe concentrations and an indirect one by toxic concentrations of the aromatic amino acid were observed. Regarding the direct effect of Phe, a possible interaction of the amino acid with the positive charged sites of the enzyme could be the basis of its action (Tsakiris et al., 1998; Doulgeraki et al., 2002) . In a recent work (Schulpis et al., 2002) , Na þ , K þ -ATPase in the erythrocyte membranes of PKU patients 'off diet' was found inhibited. Additionally, low antioxidant status was determined in the same group of PKU patients (Schulpis et al., 2003) . Obviously, these in vivo studies (Schulpis et al., 2002 (Schulpis et al., , 2003 revealed that oxidative stress may also contribute to membrane Na þ ,
MeOH is a toxicant that causes systematic toxicity. Mean peak blood MeOH concentration exceeded 2 mg/dl in subjects administered abuse doses of ASP. These MeOH concentrations are still lower than those reported in MeOH toxication (Stegink, 1987) . However, another study (Skrzydlewska and Farbiszewski, 1997) revealed that the cellular GSH content and the activity of GSH-related enzymes were decreased in MeOH intoxication. Therefore, the observed inhibition of the erythrocyte membrane Na þ , K þ -ATPase activity after incubation with high or toxic MeOH concentrations may be caused by to the production of oxidative stress as a consequence of the cellular GSH reduction (Oyama et al., 2002) . Asp, another ASP hydrolysis product, is a dicarboxylic amino acid that may exert toxic effects when administered at very high doses, although species susceptibility varies considerably (Stegink, 1987) . In this study, when high or toxic doses of Asp were incubated with erythrocyte membranes, it resulted in a significant (À26%) or remarkable (À40%) reduction of Na þ , K þ -ATPase activity, respectively.
The observed enzyme activity inhibition may be due to an increase of reactive oxygen species production and increases of intracellular Ca 2 þ by the metabolite as reported previously (Lieberman and Mody, 1994; Sureda et al., 1996) . Free radicals' attack on unsaturated bonds of membrane fatty acids results in an autocatalytic process called membrane lipid peroxidation, which can impair the function of several membrane transport proteins including Na þ , K þ -ATPase (Tsakiris et al., 2000; Lu et al., 2001) . Mg 2 þ -ATPase activity in the human erythrocyte membrane was not affected by ASP metabolites after 1 h incubation. We adapted the 1 h incubation of erythrocyte membranes with ASP according to our previous studies (Tsakiris et al., 2000) , as ASP is rapidly metabolized in the lumen after each ingestion (Stegink, 1987) . This finding may be due to the short duration of the incubation of the membranes with the sweetener or its components. This suggestion is supported by our previous findings: The rat brain Mg 2 þ -ATPase activity remained unaltered after 1 h incubation with high Phe concentrations (Doulgeraki et al., 2002) , whereas the chronic effect of high Phe blood levels resulted in a considerable inhibition of the erythrocyte enzyme activity of PKU patients 'off diet' (Schulpis et al., 2002) . Species differences and/or enzyme isoforms could not be excluded. Orally ingested ASP is immediately absorbed. Obviously, the inhibitory effects of the above mentioned ASP metabolites may simultaneously act on the erythrocyte membrane Na þ , K þ -ATPase activity by producing an acute oxidative stress and/or through the indirect influence of these metabolites on Na þ , K þ -ATPase in the membrane bilayer through lipid(s) peroxidation as also mentioned above. The absence of additional effect of ASP metabolites on the enzyme activity may be owing to the saturation of the exposed sites of the membrane enzyme by the free radicals. These suggestions are reinforced by previous (Tsakiris et al., 2000) and present findings: the addition of the commonly used antioxidants, cys or GSH, in the incubation mixture of the erythrocyte membranes with high or toxic concentrations of ASP degradation products resulted in a complete or partial prevention of the membrane enzyme inhibition, respectively. The failure of cys and GSH in fully prevention of the enzyme inhibition caused by the toxic doses of ASP metabolites (Mix 4) may be because of the weak actions of the antioxidants on the membrane enzyme as compared with the strong toxication of high concentrations of the metabolites of the sweetener, especially that of MeOH (Skrzydlewska and Farbiszewski, 1997) .
Conclusions
ASP metabolites corresponding with the 99th percentile of the daily intake of the additive may partially inhibit the erythrocyte membrane Na þ , K þ -ATPase activity, whereas a remarkable decrease of the enzyme activity was observed after incubation with hydrolysis products related to abuse doses of the sweetener. ASP metabolite concentrations commonly found in beverages did not have any effect on Na þ , K þ -ATPase activity.
Oxidative stress and/or indirect effect of ASP degradation products on the membrane bilayer through lipids peroxidation may result in the reduction of the human erythrocyte membrane Na þ , K þ -ATPase activity. This enzyme inhibition may partially explain the reported symptoms (e.g. headaches) after high doses of ASP ingestion. Erythrocyte membrane Mg 2 þ -ATPase activity remained unaltered after incubation with various concentrations of the sweetener metabolites. Cys or GSH completely or partially prevented the inhibition of the membrane enzyme activity by ASP hydrolysis parts. Erythrocyte membrane Na þ , K þ -ATPase activity evaluation may be a useful peripheral biomarker of the toxic effect of the sweetener.
